2013 Predictions











Predictions

1. SBi will continue to burn cash with no sign of profitability or intelligence.
2. Whoever the new management team is, they will realize they are completely ineffective by Q2. They will work less and/or get a new job while double-dipping from SBi coffers and will start posting negative reviews about SBi on Cafe Pharma.
3. Wherever he is, Jim Hook's moustache has refused to quit his upper lip.
4. To make sure his employees know their "place," Anthony Viscogliosi will begin spitting on them whenever he speaks. This will be known as "purple rain."
5. The STAR ankle will continue to do well, but will not triumph in a market rife with pricing pressure. The lack of a shoulder prosthesis, the leader in extremities procedures, in the portfolio will further expose this company as the sham that it is.
 












Predictions

1. SBi will continue to burn cash with no sign of profitability or intelligence.
2. Whoever the new management team is, they will realize they are completely ineffective by Q2. They will work less and/or get a new job while double-dipping from SBi coffers and will start posting negative reviews about SBi on Cafe Pharma.
3. Wherever he is, Jim Hook's moustache has refused to quit his upper lip.
4. To make sure his employees know their "place," Anthony Viscogliosi will begin spitting on them whenever he speaks. This will be known as "purple rain."
5. The STAR ankle will continue to do well, but will not triumph in a market rife with pricing pressure. The lack of a shoulder prosthesis, the leader in extremities procedures, in the portfolio will further expose this company as the sham that it is.

Anthony Viscogliosi has been moved to the board where he can do minimal damage. Unfortunately for Small Bone it is much too late.

STAR cannot and is not able to carry the company.
 



STAR revenue will decrease within the next year or 2. Some other ankles are currently in development that will be coming out into the market.

Small Bone has nothing else to drive it's revenues. The STAR was the last aquisition that could breathe life into the company.